Skip to main content
Clinical Trials/NCT06071351
NCT06071351
Active, not recruiting
Not Applicable

Motivational Interviewing Based Training Program in Adults Effect on Reducing Cardiovascular Disease Risk Factors: A Randomized Controlled Trial

Muş Alparlan University1 site in 1 country40 target enrollmentOctober 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
Muş Alparlan University
Enrollment
40
Locations
1
Primary Endpoint
change is CVD risk level
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

Aim: The aim of this study is to examine the effect of motivational interviewing-based training program on reducing cardiovascular disease risk factors in adults.

Methods: In the first stage, individuals' CVD risk levels were determined. In the second stage, a 6-session motivational interview-based training program was applied to the intervention group with a medium CVD risk level (HearthSCORE score between 2 and 5 points). Brochures were distributed to the control group.

Detailed Description

The aim of this study is to determine the CVD risks of adult individuals between the ages of 40-70 and to evaluate the effect of a motivational interview-based training program on reducing modifiable risk factors in individuals with moderate CVD risk. Hypothesis; A 6-session motivational interview-based training program aimed at reducing CVD risk factors reduces the risk level in the intervention group more than the control group. This study will be carried out in 2 stages. In the first phase, risk prevalence screening will be carried out to determine the CVD risks of individuals between October and November 2023. In the 2nd phase, a randomized controlled study will be conducted to evaluate the intervention program for individuals at medium risk level (HeartScore® between 2 and 5).

Registry
clinicaltrials.gov
Start Date
October 1, 2023
End Date
March 21, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Muş Alparlan University
Responsible Party
Principal Investigator
Principal Investigator

Hasan EVCİMEN

Principal Investigator

Muş Alparlan University

Eligibility Criteria

Inclusion Criteria

  • Being aged between 40 and 70 years,
  • Being voluntary to participate in the study,

Exclusion Criteria

  • Having a known and diagnosed CVD
  • Not being voluntary to participate in the study.

Outcomes

Primary Outcomes

change is CVD risk level

Time Frame: 24 week

In the first phase of the research, the "HeartScore®" program will be used to determine the CVD risk levels of individuals. Thanks to this program, the CVD risk levels of individuals will be learned and primary protection will be provided. According to "HeartScore®", CVD risk is discussed in 4 categories. * 10%, very high risk, * 5% - \<10%, high risk, Medium risk between ≥2-\<5%, If \<1%, they are in the low risk category. As the score increases, the CVD risk level increases.

Secondary Outcomes

  • Change in Physical Activity Level(24 week)

Study Sites (1)

Loading locations...

Similar Trials